Reporter

Lecture honors first executive director of the Meharry-Vanderbilt Alliance

The Meharry-Vanderbilt Alliance recently sponsored the Clifton K. Meador MD Inaugural Lectureship with Christopher Lathan, MD, MS, MPH, chief clinical access and equity officer, Dana-Farber Cancer Institute, serving as keynote speaker.

Vanderbilt mourns loss of former Rheumatology director Thomas

James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.

Suicide notes

Natural language processing of notes in electronic health records can identify suicidal behavior and could be used to directly improve real-time risk prediction algorithms.

Improving awareness and understanding of antimicrobial resistance is crucial

The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.

Surgery for hereditary breast cancer

Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

A marker for mortality

A urine biomarker of inflammation was associated with increased mortality and multiple lifestyle factors, suggesting that modifications could help reduce premature mortality.

1 67 68 69 70 71 770